12th HPAPI: Process Development for Highly Potent Drugs

Kongressthemen
Returning for the 12th Annual Year, the HPAPI: Process Development for Highly Potent Drugs Summit will provide benchmarking, clarity, and innovations, for the safe, cost efficient and quality development of hazardous materials in pharma and biotech.

The summit will bring together 100+ process scientists, chemists, engineers, and industrial hygienists from lab scale development to clinical and commercial manufacturing across hazardous small molecules and biologic-based therapeutics.

Wissenschaftliche Fach-Gesellschaft
Hanson Wade

Anmerkungen
Speakers: Akhil Buch | Corporate Industrial Hygienist | Hikma Pharmaceuticals, Andrew Walsh | President | Center for Pharmaceutical Cleaning Innovation, Anna Kulesza Director | CMC Pharmaceutical Development | Clovis Oncology, Brian Haney | Director

https://go.evvnt.com/1558180-2?pid=4832

Frau Stephanie Nketia